Locke, F. L., Miklos, D. B., Jacobson, C. A., Perales, M., Kersten, M., Oluwole, O. O., . . . Westin, J. R. (2022). Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma. The New England journal of medicine, 386(7), 640-654. https://doi.org/10.1056/NEJMoa2116133
Citace podle Chicago (17th ed.)Locke, Frederick L., et al. "Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma." The New England Journal of Medicine 386, no. 7 (2022): 640-654. https://doi.org/10.1056/NEJMoa2116133.
Citace podle MLA (9th ed.)Locke, Frederick L., et al. "Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma." The New England Journal of Medicine, vol. 386, no. 7, 2022, pp. 640-654, https://doi.org/10.1056/NEJMoa2116133.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..